HealthCare Global Enterprises Ltd. (HCG) AI Stock Analysis

• Market Cap: ₹95.66B
• Dividend Yield: N/A
• Average Volume (3M): 18.12K
• Price to Earnings (P/E): 265.7
• Beta (1Y): 0.44
• Revenue Growth: 17.58%
• EPS Growth: -38.20%
• Country: IN
• Employees: 6,150
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 1.47
• Shares Outstanding: 141,007,630
• 10 Day Avg. Volume: 16,611
• 30 Day Avg. Volume: 18,118
• PEG Ratio: -21.26
• Price to Book (P/B): 7.99
• Price to Sales (P/S): 3.31
• P/FCF Ratio: 68.08
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 67 Neutral
• Price Target: ₹783.00 ▲(16.53% Upside)

HealthCare Global Enterprises Ltd. benefits from strong technical momentum and solid financial performance, but its high P/E ratio suggests overvaluation. The lack of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Revenue Growth

The company's consistent revenue growth indicates a robust demand for its healthcare services, enhancing its market position and potential for future expansion.

Cash Flow Generation

Strong cash flow generation relative to net income suggests operational efficiency and the ability to fund growth initiatives without relying heavily on external financing.

Profitability Margins

Improving profitability margins reflect effective cost management and pricing strategies, which can support sustainable earnings growth over the long term.

Negative Factors

High Leverage

High leverage can increase financial risk, limiting the company's ability to invest in growth opportunities and making it vulnerable to interest rate fluctuations.

Decreasing Net Income

A decrease in net income despite revenue growth suggests potential operational inefficiencies or increased costs, which could impact profitability if not addressed.

Low Return on Equity

Low ROE indicates that the company may not be using its equity base effectively to generate profits, potentially affecting investor confidence and future capital raising.

HealthCare Global Enterprises Ltd. Business Overview & Revenue Model

Company Description

HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2021, it operated 23 cancer centers, including 1 center of excellence in Bengaluru, 2 freestanding diagnostic centers, and 1 day care chemotherapy center across India, as well as 1 cancer center in Africa. The company was founded in 1989 and is based in Bengaluru, India.

How the Company Makes Money

HCG generates revenue primarily through its healthcare services, including inpatient and outpatient treatments, surgeries, and specialized oncology services. Key revenue streams include payments from patients for treatments, consultations, and diagnostic services, as well as reimbursement from insurance companies and government health programs. Additionally, the company may earn income from partnerships with pharmaceutical firms for clinical trials and drug development, as well as from its research initiatives. HCG's strategic collaborations with healthcare providers and institutions further enhance its capabilities and market reach, contributing to its overall earnings.

HealthCare Global Enterprises Ltd. Financial Statement Overview

Summary

HealthCare Global Enterprises Ltd. shows strong revenue growth and improving profitability margins. However, the decrease in net income and high leverage indicate potential operational challenges and financial risks.

Income Statement

HealthCare Global Enterprises Ltd. has shown a strong revenue growth trajectory over the years. The company improved its revenue by 17.35% from 2024 to 2025. The gross profit margin stands at 52.11% and net profit margin at 2.00% for 2025, with a noticeable improvement in profitability metrics like EBIT and EBITDA margins, which are at 7.93% and 19.06% respectively. However, the net income has decreased compared to 2024, indicating potential operational challenges.

Balance Sheet

The company shows a moderately balanced financial structure with a debt-to-equity ratio of 1.99, indicating reliance on debt. The equity ratio at 26.02% reflects a reasonable level of equity financing. Return on Equity is low at 4.81%, suggesting limited profitability for equity holders. Overall, the balance sheet indicates a stable but leveraged position.

Cash Flow

HealthCare Global Enterprises Ltd. has demonstrated consistent positive operating cash flows, showing operational efficiency. The Operating Cash Flow to Net Income ratio is robust at 7.14, indicating strong cash flow generation relative to net income. Free Cash Flow has shown a growth of 9.39% from the previous year, reflecting healthy cash management. However, the Free Cash Flow to Net Income ratio at 2.44 highlights potential concerns in cash flow efficiency.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	23.10B	22.23B	19.12B	16.94B	13.98B	10.13B
Gross Profit	12.16B	11.91B	10.48B	9.20B	7.52B	5.27B
EBITDA	3.47B	3.13B	2.67B	2.37B	1.78B	656.22M
Net Income	370.80M	444.10M	481.55M	293.49M	537.33M	-1.93B
Balance Sheet
Total Assets	0.00	35.43B	27.07B	23.16B	22.20B	20.36B
Cash, Cash Equivalents and Short-Term Investments	3.48B	3.53B	3.03B	1.97B	2.04B	1.66B
Total Debt	0.00	18.37B	12.74B	9.01B	9.15B	9.78B
Total Liabilities	-9.90B	25.53B	18.42B	14.47B	13.36B	13.22B
Stockholders Equity	9.90B	9.22B	8.26B	8.61B	8.70B	6.97B
Cash Flow
Free Cash Flow	0.00	1.08B	988.99M	1.18B	1.49B	850.97M
Operating Cash Flow	0.00	3.17B	2.85B	2.52B	2.20B	1.21B
Investing Cash Flow	0.00	-4.88B	-2.26B	-1.33B	1.25B	-1.71B
Financing Cash Flow	0.00	-424.40M	-640.16M	-1.40B	-1.55B	1.12B

HealthCare Global Enterprises Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 671.95
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:HCG, the sentiment is Negative. The current price of 671.95 is below the 20-day moving average (MA) of 710.00, below the 50-day MA of 726.82, and above the 200-day MA of 623.31, indicating a neutral trend. The MACD of -10.11 indicates Positive momentum. The RSI at 35.53 is Neutral, neither overbought nor oversold. The STOCH value of 12.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:HCG.

HealthCare Global Enterprises Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NH	71 Outperform	₹383.21B	45.13	―	0.24%	14.72%	8.37%
HCG	67 Neutral	₹95.66B	265.66	―	―	17.58%	-38.20%
MAXHEALTH	66 Neutral	₹1.05T	77.41	―	0.14%	32.17%	28.12%
MEDANTA	65 Neutral	₹320.34B	57.00	―	0.04%	15.78%	15.01%
ASTERDM	62 Neutral	₹309.76B	91.60	―	0.84%	-36.14%	-93.99%
FORTIS	61 Neutral	₹681.12B	67.17	―	0.11%	15.33%	54.62%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

HealthCare Global Enterprises Ltd. Corporate Events

HealthCare Global Releases Investor Meet Recording Highlighting Growth Plans

HealthCare Global Enterprises Ltd. announced the availability of an audio recording from its recent Virtual Investor & Analyst Meet, which discussed the company’s business strategy and long-term growth plans. This move is likely to enhance transparency and provide stakeholders with insights into the company’s future direction, potentially impacting its market positioning and investor relations.

HealthCare Global Enterprises Ltd. Holds 27th AGM Virtually

HealthCare Global Enterprises Ltd. conducted its 27th Annual General Meeting on September 25, 2025, via video conferencing, adhering to regulatory guidelines. The meeting included the presence of key directors and auditors, reflecting the company’s commitment to transparency and compliance, which is crucial for maintaining stakeholder trust and enhancing its market position.